Repligen Corporation (RGEN) — Analyst outlook / Analyst consensus target is. Based on 23 analyst ratings, the consensus is bullish — 1 Strong Buy, 19 Buy, 3 Hold.
The consensus price target is $183.00 (low: $160.00, high: $200.00), representing an upside of 39.7% from the current price $131.03.
Analysts estimate Earnings Per Share (EPS) of $1.54 and revenue of $0.63B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.46 vs est $1.54 (missed -129.9%). 2025: actual $0.87 vs est $1.66 (missed -47.7%). Analyst accuracy: 0%.
RGEN Stock — 12-Month Price Forecast
$183.00
▲ +39.66% Upside
Average Price Target
Based on 23 Wall Street analysts offering 12-month price targets for Repligen Corporation, the average price target is $183.00, with a high forecast of $200.00, and a low forecast of $160.00.
The average price target represents a +39.66% change from the last price of $131.03.
Highest Price Target
$200.00
Average Price Target
$183.00
Lowest Price Target
$160.00
RGEN Analyst Ratings
Buy
Based on 23 analysts giving stock ratings to Repligen Corporation in the past 3 months
EPS Estimates — RGEN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.46
vs Est $1.54
▼ 434.4% off
2025
Actual $0.87
vs Est $1.66
▼ 91.3% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — RGEN
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.634B
vs Est $0.634B
▲ 0.0% off
2025
Actual $0.738B
vs Est $0.733B
▲ 0.7% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
